FAS and neoplasm: Among mono-substituted Fas analogs, 3-chlorofascaplysin (47, Figure 11) induces apoptosis via metabolic stress and exhibits antiangiogenic activity, reducing Ehrlich carcinoma tumor growth by 30% at 7 mg/kg over 7 days [136].